儿童头颈部非横纹肌肉瘤软组织肉瘤临床研究

doi:10.3969/j.issn.1006-7795.2019.06.020

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (6): 921-926.doi: 10.3969/j.issn.1006-7795.2019.06.020

儿童头颈部非横纹肌肉瘤软组织肉瘤临床研究

段超¹, 王生才², 金眉¹, 张大伟¹, 赵文¹, 王希思¹, 赵倩¹, 邰隽², 张杰², 何乐建³, 张建国⁴, 倪鑫², 马晓莉¹

1. 国家儿童医学中心首都医科大学附属北京儿童医院血液肿瘤中心儿科学国家重点学科儿科重大疾病研究教育部重点实验室, 北京 100045;
2. 国家儿童医学中心首都医科大学附属北京儿童医院耳鼻咽喉头颈外科, 北京 100045;
3. 国家儿童医学中心, 首都医科大学附属北京儿童医院病理科, 北京 100045;
4. 北京大学口腔医院颌面外科, 北京 100081

收稿日期:2019-02-15 出版日期:2019-11-21 发布日期:2019-12-18
通讯作者: 马晓莉 E-mail:mxl1123@vip.sina.com
基金资助:
北京市医院管理局儿科学科协同发展中心专项经费资助（XTYB201803）。

Clinical features and outcome regarding head and neck non-rhabdomyosarcoma soft tissue sarcoma in children

Duan Chao¹, Wang Shengcai², Jin Mei¹, Zhang Dawei¹, Zhao Wen¹, Wang Xisi¹, Zhao Qian¹, Tai Jun², Zhang Jie², He Lejian³, Zhang Jianguo⁴, Ni Xin², Ma Xiaoli¹

1. Beijing Key Laboratory of Pediatric Hematology Oncology;National Key Discipline of Pediatrics, Ministry of Education;Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
2. Department of Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
3. Department of Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
4. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China

Received:2019-02-15 Online:2019-11-21 Published:2019-12-18
Supported by:
This study was founded by Special Fund of The Pediatric Medical Coordinated Development Center of Beijing Municipal Administration of Hospitals (XTYB201803)

摘要/Abstract

摘要： 目的总结多学科联合诊治头颈部非横纹肌肉瘤软组织肉瘤患儿的临床特征及近期疗效，以指导临床诊疗。方法将2012年10月至2018年2月期间本中心收治的头颈部非横纹肌肉瘤软组织肉瘤病例连续纳入研究。治疗采用包括手术、化学药物治疗（以下简称化疗）及局部放射治疗（以下简称放疗）在内的多学科联合诊治模式；局部放疗方式的选择包括外放疗、质子治疗及¹²⁵I粒子植入治疗。分析患儿的临床特征及治疗效果。结果本中心收治的11例头颈部非横纹肌肉瘤软组织肉瘤患儿，年龄1.1~12岁，中位年龄5.6岁，其中男性7例，女性4例；病理类型包括：恶性横纹肌样瘤3例，滑膜肉瘤2例，婴儿型纤维肉瘤2例，孤立型纤维肉瘤1例，恶性神经鞘瘤1例；伴有CIC-DUX4易位的小圆细胞肉瘤1例，未分类的小圆细胞肉瘤1例。2例婴儿型纤维肉瘤患儿行ETV6-NTRK3融合基因检测，结果均为阴性。2例滑膜肉瘤患儿SYT-SSX融合基因均为阳性。肿瘤直径≥5 cm者6例，<5 cm者5例；6例患儿无区域淋巴结转移，5例存在区域淋巴结转移；有远处转移者3例，余8例患儿不存在远处转移，其中2例患儿为肺转移，1例患儿为骨、骨髓、胰腺及多发淋巴结转移。5例患儿行手术治疗，6例患儿仅行活检。全部患儿均接受化疗。3例患儿行外放疗，4例患儿未放疗，4例患儿行¹²⁵I粒子植入治疗。随诊时间10~78个月，中位随诊时间19个月。治疗后8例完全缓解，1例部分缓解，1例死亡，1例治疗中发生肺转移仍在治疗中。生存分析结果显示：本组患儿预计平均生存时间为（64.7±6.9）个月（95%CI：51.1~78.2）。1年总生存率及无事件生存率均为（88.9±10.5）%。结论手术联合化疗及放疗是头颈部非横纹肌肉瘤软组织肉瘤患儿的有效治疗措施，近期疗效较理想，但仍需进一步随诊观察。远处转移是导致治疗失败的主要原因。

关键词: 儿童, 头颈部, 非横纹肌肉瘤软组织肉瘤, 恶性横纹肌样瘤, CIC-DUX4易位的小圆细胞肉瘤

Abstract: Objective The purpose for this study was to explore the clinical presentation, treatment, survival and risk factors of head and neck non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in pediatric patients. Methods The clinical data of head and neck NRSTS patients diagnosed between Oct.2012 and Feb.2018 were retrospectively studied. Clinical features, treatment and outcomes were analyzed. Results Eleven patients were enrolled in this study, including 7 boys and 4 girls, with a median age of 5.6 years. Including malignant rhabdoid tumors(n=3),synovial sarcoma(n=2), fibrosarcoma(n=3), malignant neurilemmoma(n=1), undifferentiated small round cell sarcomas with CIC-DUX4 fusion (n=1), and undifferentiated small round cell sarcomas (n=1). The primary site of the tumor including neck (n=4), scalp and facial soft tissue (n=3), oral cavity and oropharynx(n=3), and fossae infratemporalis (n=1). The diameter of the tumor ≥ 5 cm(n=6),<5 cm(n=5). Six patients had local lymph node metastasis, and 3 patients had distant metastasis. All patients(n=11) received systemic chemotherapy, radiation therapy was carried out in 3 patients, 4 patients received ¹²⁵I particle implantation, 4 patients did not receive any adjuvant radiation. Surgery was performed in 5 patients, and 6 patients only received biopsy. The follow-up time was 10-78 month, and median follow-up time was 19 month. The estimated mean survival time was (64.7±6.9) month (95%CI:51.1-78.2%). The 1-year overall survival was (88.9±10.5)%. Conclusion In this series, most of the pediatric head and neck NRSTS are nonmetastatic, and the short-term outcome is favorable. ¹²⁵I particle implantation is effective for local control, and improved systemic therapies are needed for patients with metastatic disease.

Key words: children, head and neck, non-rhabdomyosarcoma soft tissue sarcoma, malignant rhabdoid tumor, undifferentiated small round cell sarcomas with CIC-DUX4 fusion

中图分类号:

R739.91

段超, 王生才, 金眉, 张大伟, 赵文, 王希思, 赵倩, 邰隽, 张杰, 何乐建, 张建国, 倪鑫, 马晓莉. 儿童头颈部非横纹肌肉瘤软组织肉瘤临床研究[J]. 首都医科大学学报, 2019, 40(6): 921-926.

Duan Chao, Wang Shengcai, Jin Mei, Zhang Dawei, Zhao Wen, Wang Xisi, Zhao Qian, Tai Jun, Zhang Jie, He Lejian, Zhang Jianguo, Ni Xin, Ma Xiaoli. Clinical features and outcome regarding head and neck non-rhabdomyosarcoma soft tissue sarcoma in children[J]. Journal of Capital Medical University, 2019, 40(6): 921-926.

参考文献

[1] 樊征夫, 李舒, 方志伟, 等. 儿童非横纹肌肉瘤软组织肉瘤的美国儿童肿瘤协作组危险度评估与综合治疗单中心研究[J]. 中华实用儿科临床杂志, 2016, 31(7):535-539.
[2] Federico S M, Gilpin D, Samant S, et al. Clinical features and outcomes of young patients with head and neck non-rhabdomyosarcoma soft tissue sarcomas[J]. Head Neck, 2015, 37(1):76-83.
[3] Pang A, Carini M, Maki R G. Contemporary therapy for adcanced soft-tissue sarcoma in adults:A review[J]. JAMA Onco, 2016, 2(7):941-947.
[4] Tudor-Green B, Gomez R, Brennan P A. Current update on the diagnosis and management of head and neck soft tissue sarcoma[J]. J Oral Pathol Med, 2017, 46(9):674-679.
[5] Million L, Donaldson S S. Resectable pediatric nonrhabdoyosarcoma soft tissue sarcoma:which patients benefit from adjuvant radiation therapy and how much?[J]. ISRN Oncol, 2012, 2012:341408.
[6] Spunt S L, Pappo A S. Childhood non-rhabdomyosarcoma soft tissue sarcomas are not adult type tumors[J]. J Clin Oncol, 2006,24(12):1958-1959.
[7] Pappo A S, Rao B N, Jenkins J J, et al. Metastatic non-rhabdomyosarcomatous soft-tissue sarcomas in children and adolescents:the St. Jude Children's Research Hospital experience[J]. Med Pediatr Oncol, 1999,33(2):76-82.
[8] Tinkle C L, Fernandez-Pineda I, Sykes A, et al. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in pediatric and young adult patients:Results from a prospective study using limited-margin radiotherapy[J]. Cancer, 2017,123(22):4419-4429.
[9] Cahlon O, Brennan M F, Jia X, et al. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation[J]. Ann Surg, 2012,255(2):343-347.
[10] Waxweiler T V, Rusthoven C G, Proper M S, et al. Non-rhabdomyosarcoma soft tissue sarcoma in Children:A suveilance, epidemiology, and end results analysis validating COG risk stratification[J]. Int J Radiat Oncol Bio Phys, 2015, 92(2):339-348.
[11] Alektiar K M, Brennan M F, Singer S. Local control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity[J]. Cancer, 2011,117(14):3229-3234.
[12] Childs S K, Kozak K R, Friedmann A M, et al. Proton radiotherapy for parameningeal rhabdomyosarcoma:clinical outcomes and late effects[J]. Int J Radiat Oncol Biol Phys, 2012,82(2):635-642.
[13] Wasif N, Smith C A, Tamurian R M, et al. Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissuesarcoma of the extremities[J]. JAMA Surg, 2013, 148(7):632-639.
[14] Felderhof J M, Creutzberg C L, Putter H, et al. Long-term clincal outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy[J]. Acta Oncol, 2013,52(4):745-752.
[15] Daigeler A, Harati K, Goertz O, et al. Prognostic factors and surgical tactics in patients with locally recurrent soft tissue sarcomas[J]. Handchir Mikrochir Plast Chir,2015, 47(2):118-127.
[16] Duan C, Zheng L,Zhang D W,et al.Treatment of malignant rhabdoid tumors of the head and neck with combined chemotherapy and 125I particle implantation[J].Pediatr Invest,2018,2(1):53-55.
[17] Rehders A, Hosch S B, Scheunemann P, et al. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma[J]. Arch Surg, 2007, 142(1):70-75.
[18] Paulino A C, Ritchie J, Wen B C. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma[J]. Pediatr Blood Cancer, 2004, 43(5):587-593.
[19] 肖绍文, 刘长青,方志伟,等.软组织肉瘤术后放疗392例临床观察[J].中华肿瘤防治杂志,2018,25(8):578-580,585.
[20] Kawai A, Woodruff J, Healey J H, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma[J]. N Engl J Med, 1998, 338(3):153-160.
[21] Adem C, Gisselsson D, Dal Cin D, et al. ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescense in situ hybridization[J]. Mod Pathol, 2001,14(12):1246-1251.
[22] Choi E Y, Thomas D G, McHugh J B, et al. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion:a noval highly aggressive soft tissue tumor with distinctive histopathology[J]. Am J Surg Pathol, 2013,37(9):1379-1386.

儿童头颈部非横纹肌肉瘤软组织肉瘤临床研究

Clinical features and outcome regarding head and neck non-rhabdomyosarcoma soft tissue sarcoma in children

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李昂, 皇惠杰, 杨世青, 侯晓玲, 向莉. 长程治疗管理哮喘儿童的肺功能轨迹特征分析[J]. 首都医科大学学报, 2022, 43(6): 940-947.
[2]	张志丽, 郭彩霞. 头颈部恶性肿瘤术后急性肺栓塞临床特点及危险因素分析[J]. 首都医科大学学报, 2022, 43(5): 787-791.
[3]	吴鸿波, 李曼曼, 林丽丽, 李丽华. 单中心儿科门急诊0~16岁儿童10年死亡数据分析[J]. 首都医科大学学报, 2021, 42(5): 852-856.
[4]	马佳佳, 岳红丽, 王德祥, 金旭, 韩如泉. 不同剂量右美托咪定对儿童颅脑术后苏醒期躁动的影响[J]. 首都医科大学学报, 2021, 42(3): 459-463.
[5]	王振民, 宫剑. 儿童开颅术后脑脊液外引流与颅内感染的相关性研究[J]. 首都医科大学学报, 2021, 42(2): 269-272.
[6]	张鹏, 王争, 李佳, 王振常. 大数据时代下头颈部影像信息学的开拓者——王振常教授[J]. 首都医科大学学报, 2020, 41(5): 828-833.
[7]	贾晨光, 周翾, 王彬, 朱光华, 秦茂权. 异基因造血干细胞移植治疗儿童急性髓系白血病的临床观察[J]. 首都医科大学学报, 2019, 40(2): 163-168.
[8]	王希思, 杨维, 黄程, 赵文, 赵倩, 段超, 苏雁, 金眉, 张大伟, 秦红, 王焕民, 马晓莉. 儿童肝母细胞瘤的临床特征和治疗效果评价[J]. 首都医科大学学报, 2019, 40(2): 169-173.
[9]	张利强, 陈振萍, 郑杰, 马洁, 吴润晖. 国产甲磺酸伊马替尼治疗儿童慢性髓系白血病慢性期的早期疗效和安全性分析[J]. 首都医科大学学报, 2019, 40(2): 174-178.
[10]	张金, 任思其, 李舒婷, 李苗, 龚小军, 孙艳玲, 武万水, 孙黎明, 杜淑旭. 脑脊液肿瘤坏死因子-α和干扰素-γ对髓母细胞瘤患儿的预后评价分析[J]. 首都医科大学学报, 2019, 40(2): 201-204.
[11]	张利强, 郑杰, 马洁, 陈振萍, 吴润晖. 9例具有致病基因变异的儿童期原发性血小板增多症临床分析[J]. 首都医科大学学报, 2018, 39(4): 607-611.
[12]	李莹, 祁森荣, 华琳, 尚佳健. 儿童复发性腮腺炎患者与正常儿童腮腺液微生物群落多样性的差异[J]. 首都医科大学学报, 2018, 39(3): 453-457.
[13]	李文风, 文宏伟, 刘玥, 彭芸, 程华, 李宏彬, 邰隽. 弥散峰度成像对儿童阻塞性睡眠呼吸暂停综合征脑微结构变化的研究[J]. 首都医科大学学报, 2018, 39(2): 178-184.
[14]	皇惠杰, 刘晓颖, 侯晓玲, 苗青, 向莉. 尘螨变应原免疫治疗联合药物治疗对哮喘合并变应性鼻炎患儿临床疗效及气道高反应性的影响[J]. 首都医科大学学报, 2016, 37(5): 568-573.
[15]	王昊, 徐保平, 申昆玲. 囊性纤维化及中国儿童特点[J]. 首都医科大学学报, 2016, 37(5): 588-592.